Or. Rev. Stat. § 689.802 – Prescription of short-acting opioid antagonist

(1) As used in this section:
1. (a) “Opioid” means a natural, synthetic or semisynthetic chemical that interacts with opioid receptors on nerve cells in the body and brain to reduce the intensity of pain signals and feelings of pain.
2. (b) “Opioid overdose” means a medical condition that causes depressed consciousness, depressed respiratory function or the impairment of vital bodily functions as a result of ingesting opioids.
3. (c) “Short-acting opioid antagonist” means any short-acting drug approved by the United States Food and Drug Administration for the complete or partial reversal of an opioid overdose.
(2) In accordance with rules adopted by the State Board of Pharmacy under ORS 689.205, a pharmacist may prescribe a short-acting opioid antagonist and the necessary medical supplies to administer the short-acting opioid antagonist.
(3) If a prescription is presented to a pharmacist for dispensing an opiate or opioid in excess of a morphine equivalent dose established by rule by the board, the pharmacist may offer to prescribe and provide, in addition to the prescribed opiate or opioid, a short-acting opioid antagonist and the necessary medical supplies to administer the short-acting opioid antagonist. [Formerly 689.682]